Real ChatGPT answer · index seedD1gPOc3weRocompleteHealth and wellness · pharmacies and prescriptionsinformational
How do pharmacy benefit managers determine formulary tiers for brand name biologics, and what is the appeals process when a tier exception is denied?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
How do pharmacy benefit managers determine formulary tiers for brand name biologics, and what is the appeals process when a tier exception is denied?
4 real searches · 1 real-search pass
US health insurance formulary tier exception appeal process external review CMS ERISA biologics PBM P&T committee guidanceGoogle ↗
OBSERVED
CMS Medicare Part D formulary exception tiering exception appeal deadlines 2026 officialGoogle ↗
OBSERVED
HealthCare.gov internal appeals external review formulary exception prescription drug tier officialGoogle ↗
OBSERVED
Department of Labor ERISA claims appeals prescription drug formulary exception deadlines officialGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 4 queries…
Searches and sources
ChatGPT4 real searches · gpt-6
US health insurance formulary tier exception appeal process external review CMS ERISA biologics PBM P&T committee guidance Google ↗
CMS Medicare Part D formulary exception tiering exception appeal deadlines 2026 official Google ↗
HealthCare.gov internal appeals external review formulary exception prescription drug tier official Google ↗
Department of Labor ERISA claims appeals prescription drug formulary exception deadlines official Google ↗
- Exceptions · cms.gov
- Appeals in a Medicare drug plan · medicare.gov
- Appeals Overview · cms.gov
- External Review · healthcare.gov
- HHS-Administered Federal External Review Process for Health Insurance Coverage · cms.gov
Queries
4 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
US health insurance formulary tier exception appeal process external review CMS ERISA biologics PBM P&T committee guidance OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
CMS Medicare Part D formulary exception tiering exception appeal deadlines 2026 official OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
HealthCare.gov internal appeals external review formulary exception prescription drug tier official OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
Department of Labor ERISA claims appeals prescription drug formulary exception deadlines official OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |